Blood-based Biomarker for Alzheimer’s Disease Market Analysis of Current and Future Industry Trends and Growth till 2035
The global blood-based biomarker for Alzheimer’s disease market is emerging as a transformative segment within the broader neurodiagnostics and precision medicine landscape. Alzheimer’s disease, a progressive neurodegenerative disorder, continues to impose a significant clinical, social, and economic burden worldwide. Traditional diagnostic approaches relying on cerebrospinal fluid...
0 Comments 0 Shares 12 Views